First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 7, 2024

Pear Therapeutics Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Net Income (Common) Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Net Income (Common)
-$75.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Net Income (Common)
$525.7m
CAGR 3-Years
11%
CAGR 5-Years
18%
CAGR 10-Years
48%
Inspire Medical Systems Inc
NYSE:INSP
Net Income (Common)
-$21.2m
CAGR 3-Years
28%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Net Income (Common)
-$142.3m
CAGR 3-Years
25%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Net Income (Common)
$112.8m
CAGR 3-Years
119%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Net Income (Common)
-$8.9m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Net Income (Common)?
Net Income (Common)
-75.5m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Net Income (Common) amounts to -75.5m USD.

What is Pear Therapeutics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-16%

Over the last year, the Net Income (Common) growth was -16%.